| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $108.8M | +55.2% |
| SG&A Expense | $49.4M | +51.2% |
| Operating Income | -$158.2M | -54.0% |
| Pre-tax Income | -$122.2M | -36.7% |
| Income Tax | $310K | +31.4% |
| Net Income | -$122.5M | -36.7% |
| EPS (Basic) | -$0.78 | +3.7% |
| EPS (Diluted) | -$0.78 | +3.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $169.5M | +30.6% |
| Short-term Investments | $714.0M | +111.5% |
| Current Assets | $891.2M | +88.2% |
| Total Assets | $903.3M | +87.4% |
| Current Liabilities | $36.0M | +45.6% |
| Total Liabilities | $38.5M | +32.5% |
| Stockholders' Equity | $864.8M | +90.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$116.6M | -46.7% |
| Capital Expenditures | $1.3M | -40.5% |
| Investing Cash Flow | -$358.9M | -33.8% |
| Financing Cash Flow | $515.3M | +14.1% |
| Free Cash Flow | -$117.9M | -44.4% |